# nintedanib

NDC: 73190-097
Generic name: nintedanib
Labeler / Manufacturer: AvKARE
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20260721

FDA application: ANDA212555

## Active ingredients

- NINTEDANIB ESYLATE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73190-097"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73190-097
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=572722d7-338a-e4d2-e063-6394a90a257c